Inici › Melanoma › Minnesota › Minneapolis
Assaigs clínics de Melanoma a Minneapolis, MN
12 estudis de Melanoma busquen participants en centres de Minneapolis i voltants (en un radi d'uns 30 milles). Obre un estudi per veure qui hi pot participar i com contactar amb l'equip.
Text oficial de l'estudi (anglès)
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
ReclutantEstudi observacionalVoluntaris sans benvinguts
- Abbott-Northwestern Hospital, Minneapolis
- Hennepin County Medical Center, Minneapolis
- Park Nicollet Clinic - Saint Louis Park, Saint Louis Park · a 5 mi
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
ReclutantFase 2
- Health Partners Frauenshuh Cancer Center, Saint Louis Park · a 5 mi
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
ReclutantFase 2
- Abbott-Northwestern Hospital, Minneapolis
- Park Nicollet Clinic - Saint Louis Park, Saint Louis Park · a 5 mi
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
ReclutantFase 3
- Allina Health Cancer Institute, Minneapolis
Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma.
ReclutantFase 3
- University of Minnesota, Minneapolis
Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
ReclutantFase 1/2
- Minnesota Oncology and Hematology PA, Minneapolis
A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases
ReclutantFase 2
- Abbott-Northwestern Hospital, Minneapolis
- Hennepin County Medical Center, Minneapolis
- Health Partners Inc, Minneapolis
- i 1 més
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
ReclutantFase 1/2
- University of Minnesota/Masonic Cancer Center, Minneapolis
Project: Every Child for Younger Patients With Cancer
ReclutantEstudi observacional
- Children's Hospitals and Clinics of Minnesota - Minneapolis, Minneapolis
- University of Minnesota/Masonic Cancer Center, Minneapolis
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
ReclutantFase 1/2
- M Health Fairview University of Minnesota Medical Center, Minneapolis
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
ReclutantEstudi observacional
- Abbott-Northwestern Hospital, Minneapolis
- Hennepin County Medical Center, Minneapolis
- Park Nicollet Clinic - Saint Louis Park, Saint Louis Park · a 5 mi
Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)
ReclutantFase 3
- University of Minnesota Medical Center, Minneapolis
Assaigs de Melanoma en altres ciutats
- Houston, TX59 estudis
- New York City, NY38 estudis
- Los Angeles, CA34 estudis
- Nashville, TN33 estudis
- Pittsburgh, PA31 estudis
- Boston, MA26 estudis
- Philadelphia, PA23 estudis
- San Francisco, CA22 estudis
- Durham, NC21 estudis
- Atlanta, GA21 estudis
- St. Louis, MO21 estudis
- Salt Lake City, UT21 estudis
Altres estudis a Minneapolis
- Càncer de mama27 estudis
- Càncer de pulmó de cèl·lules no petites26 estudis
- Càncer d'ovari24 estudis
- Càncer de pròstata23 estudis
- Càncer (tots els tipus)22 estudis
- Insuficiència cardíaca21 estudis
- Càncer de pulmó20 estudis
- Leucèmia mieloide aguda20 estudis
- Càncer colorrectal19 estudis
- Càncer d'endometri18 estudis
- Malaltia de Parkinson17 estudis
- Malaltia cardiovascular15 estudis
De ClinicalTrials.gov, dades recuperades el 5 d’oct. 2026. Cada estudi estableix els seus propis criteris d'elegibilitat; l'equip de l'estudi decideix qui hi pot participar.